CMG News 673.00 08/07/2014 04:49:34 Chipotle Mexican Grill (

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Chipotle Mexican Grill (CMG) 673.00 $CMG

Final Glance: Restaurant companies
AP - Wed Aug 06, 5:02PM CDT
NEW YORK (AP) — Shares of some top restaurant companies were mixed at the close of trading:

Will News Corp (NWSA) Earnings Disappoint This Quarter? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 06, 4:45PM CDT
News Corporation (NWSA), a diversified media and information services conglomerate, is slated to report fourth-quarter fiscal 2014 results on Aug 7.

Will Central Garden & Pet (CENT) Q3 Earnings Miss Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 06, 4:20PM CDT
Our proven model does not conclusively project Central Garden & Pet Company (CENT) as liklely to beat earnings this quarter.

Midday Glance: Restaurant companies
AP - Wed Aug 06, 12:23PM CDT
NEW YORK (AP) — Shares of some top restaurant companies are mixed at 1 p.m.:

Chipotle Is the New Chipotle
Rick Munarriz, The Motley Fool - Motley Fool - Wed Aug 06, 12:02PM CDT
There have been a lot of hot restaurant IPOs hitting the market over the past couple of years, and it's a safe bet that they wouldn't have had much of a chance to woo retail investors if it weren't for Chipotle Mexican Grill : Underwriters wouldn't...

Is the Potbelly Growth Story Already Dead?
Sean Williams, The Motley Fool - Motley Fool - Wed Aug 06, 11:07AM CDT
Investors expected to get high off the hog, and consumers expected to be healthfully fed; but is the growth story behind Potbelly already dead? When Potbelly announced its intention to become a publicly traded company more than a year ago, the ...

Early Glance: Restaurant companies
AP - Wed Aug 06, 9:32AM CDT
NEW YORK (AP) — Shares of some top restaurant companies are mixed at 10 a.m.:

Papa John's (PZZA) Misses on Q2 Earnings, Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 06, 9:10AM CDT
Papa John's International, Inc. (PZZA) posted second quarter 2014 results with earnings of 40 cents per share missing the Zacks Consensus Estimate of 41 cents by a penny.

Famous Dave's of America (DAVE) Beats Q2 Earnings & Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 06, 9:04AM CDT
Famous Dave's of America Inc. (DAVE) reported second-quarter 2014 results, wherein both earnings per share and revenues beat the Zacks Consensus Estimate.

Jamba (JMBA) Soars: Stock Adds 11.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Aug 06, 8:04AM CDT
Jamba, Inc. (JMBA) was a big mover last session, as the company saw its shares rise over 11% on the day.

Kia Sales Got Soul While Tesla's U.S. Sales Are Superbad
at The Street - Wed Aug 06, 5:00AM CDT
Kia Soul U.S. sales are up 23% so far this year while Tesla���s U.S. sales decline. What gives?

Top Performing Funds Play Favorits
at Investor's Business Daily - Tue Aug 05, 5:30PM CDT
The nation's top-performing funds the past three months have been ramping up their buying of medical and Internet stocks. They've had varying degrees of success resisting the downward pull of the stock market in July Large drug providers, such as...

Will Time Warner's (TWX) Initiatives Drive Q2 Earnings Beat? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 4:40PM CDT
We expect Time Warner Inc. (TWX), a media and entertainment company, to beat expectations when it reports second-quarter 2014 results on Aug 6.

Bloomin' Brands Wilts On Lower Earnings Outlook
at Investor's Business Daily - Tue Aug 05, 12:45PM CDT
Bloomin' Brands (BLMN) shares took a huge dive as the operator of Outback Steakhouse, Fleming's, Roy's and other restaurants lowered its earnings outlook and missed second-quarter earnings views. New restaurant openings, a rise in domestic same-store...

Jamba Beats Q2 Earnings on Stronger Comps; Maintains View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 11:30AM CDT
Jamba, Inc. (JMBA) posted mixed second-quarter 2014 results wherein earnings beat the Zacks Consensus Estimate, but revenues missed the consensus mark.

Prestigious Accreditation, Event Update, Financial Performance, Market Activity, and Donations - Research Reports on CVS Caremark, Chipotle, Time Warner, Costco and Staples
PR Newswire - Tue Aug 05, 8:10AM CDT
Today, Analysts Review released its research reports regarding CVS Caremark Corporation (NYSE: CVS), Chipotle Mexican Grill, Inc. (NYSE: CMG), Time Warner Cable Inc. (NYSE: TWC), Costco Wholesale Corporation (NASDAQ: COST) and Staples, Inc. (NASDAQ: SPLS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5447-100free.

The Zacks Analyst Blog Highlights: Yum! Brands, McDonald's, BJ's Restaurants, Chipotle Mexican Grill and Papa John's International
PR Newswire - Tue Aug 05, 6:41AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Yum! Brands, Inc. (NYSE:YUM-Free Report), McDonald's Corp. (NYSE:MCD-Free Report), BJ's Restaurants, Inc. (Nasdaq:BJRI-Free Report), Chipotle Mexican Grill, Inc. (NYSE:CMG-Free Report) and Papa John's International Inc. (Nasdaq ZZA-Free Report).
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 311

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 150

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 364

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 105

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 354

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 35

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

VIQ Solutions' Leadership Transition Marks New Era Ahead

Updated Category News Views 244

VIQ Solutions Marks a New Chapter with Leadership Changes VIQ Solutions Inc. is making noteworthy changes in its executive team that will undoubtedly shape the organization's path forward. The firm, known for being a global provider of AI-driven, secure digital voice and video capture technology, has announced the retirement of Susan Sumner, who has been a pivotal figure...

Continue Reading
Lucid Group's Fourth Quarter Success: Record Deliveries Ahead

Updated Category News Views 130

Lucid Group Inc Reports Strong Q4 Earnings Lucid Group Inc (NASDAQ: LCID) has revealed its fourth-quarter financial results, demonstrating a significant improvement in revenue and production metrics. The results were reported after the market closed on a recent Tuesday, showcasing the company's ongoing commitment to innovation in the electric vehicle sector. Revenue...

Continue Reading
Verily Sightline Collaborates with Bangor University in Europe

Updated Category News Views 149

Verily Partners with Bangor University for Wastewater Testing Verily, recognized for its precision health technology, is extending its wastewater surveillance program into Europe through a promising partnership with Bangor University. This collaboration aims to take advantage of the innovative wastewater-based public health programs at Bangor to enhance testing...

Continue Reading
Amaero's Strategic Supply Agreement Boosts U.S. Titanium Production

Updated Category News Views 213

Amaero Secures Strategic Long-Term Supply Agreement Significant Milestone in Domestic Supply Chain Development Amaero International Limited (ASX:3DA), a prominent U.S. manufacturer of high-quality titanium powders, has successfully signed a three-year Supply Agreement with The Perryman Company, a leader in titanium production. This agreement marks a pivotal moment in...

Continue Reading
NextPlat: Insights from Interim CEO on Future Directions

Updated Category News Views 132

NextPlat Corp's Interim CEO Update NextPlat Corp (NASDAQ: NXPL), a prominent player in the consumer products and services sector, recently issued a pivotal update from its interim CEO, David Phipps. This detailed letter serves as a roadmap to navigate the company’s future after the unexpected passing of its former CEO, Charles M. Fernandez. The focus is on leveraging...

Continue Reading